Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

846
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
846
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

319
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
319
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

14.6K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
14.6K
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

445
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
445
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

332
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
332
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

354
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
354

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IL4I1+ Macrophage Accumulation in Advanced Cutaneous T-Cell Lymphomas Suggests a Role in Tumor Immune Escape.

The Journal of investigative dermatology·2026
Same author

French national protocol for diagnosis and management of pemphigoid gestationis.

Annales de dermatologie et de venereologie·2026
Same author

Reporting of withdrawn participants in randomized controlled trials assessing targeted therapies in immune-mediated skin diseases: a cross-sectional study of trials from systematic reviews.

Journal of clinical epidemiology·2026
Same author

Development of a shared decision-making tool for systemic treatment in psoriasis.

Annales de dermatologie et de venereologie·2026
Same author

Comparison between risk of bias-1 and risk of bias-2 tool and impact on network meta-analysis results-A case study from a living Cochrane review on psoriasis.

Journal of clinical epidemiology·2025
Same author

French national protocol for diagnosis and management of drug reaction with eosinophilia and systemic symptoms (DRESS) in adults and children.

Annales de dermatologie et de venereologie·2025
Same journal

Environmental criteria in dermatology research grants.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same journal

Microneedling with adipose MSC exosomes versus monotherapy for androgenetic alopecia.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same journal

Diabetes and melanoma: Impact on prognosis and healthcare costs.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same journal

Differential survival with adjuvant immunotherapy in stage III acral versus non-acral melanoma.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same journal

Estimating the global burden of mental health disorders associated with atopic dermatitis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same journal

Proteomic analysis in hidradenitis suppurativa reveals systemic inflammation in all disease stages.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
See all related articles

Related Experiment Video

Updated: Mar 28, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

11.2K

Dermatomyositis: factors predicting relapse.

V Vuong1, T A Duong1, J Aouizerate2,3

  • 1AP-HP, DHU-VIC, Service de Dermatologie, Hôpitaux universitaires Henri Mondor, Créteil, France.

Journal of the European Academy of Dermatology and Venereology : JEADV
|December 17, 2015
PubMed
Summary
This summary is machine-generated.

Dermatomyositis relapses, causing significant morbidity, can be predicted by early signs. Dysphonia and severe skin lesions (CDASI > 20) at diagnosis indicate a higher risk of disease recurrence in dermatomyositis patients.

More Related Videos

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
10:55

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

1.0K
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

1.0K

Related Experiment Videos

Last Updated: Mar 28, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

11.2K
Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
10:55

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

1.0K
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

1.0K

Area of Science:

  • Rheumatology
  • Dermatology
  • Clinical Medicine

Background:

  • Dermatomyositis (DM) is a chronic autoimmune disease characterized by relapses, leading to significant patient morbidity.
  • Understanding predictors of disease course is crucial for managing chronic inflammatory myopathies.

Purpose of the Study:

  • To identify clinical features at disease onset that predict future relapses in dermatomyositis patients.
  • To improve prognostication and personalize treatment strategies for dermatomyositis.

Main Methods:

  • Retrospective analysis of 34 dermatomyositis patients diagnosed between 1990 and 2011.
  • Comparison of patient characteristics, including muscle biopsy data, between those who relapsed and those who did not.
  • Utilized Cox proportional hazards models to estimate hazard ratios (HRs) for relapse predictors.

Main Results:

  • A relapsing disease course was observed in 61% of the identified dermatomyositis patients.
  • Dysphonia (voice impairment) was significantly associated with a higher risk of relapse (HR = 3.2).
  • Greater skin lesion severity, defined by a Cutaneous Disease Area Severity Index (CDASI) > 20, also predicted relapses (HR = 3.5).

Conclusions:

  • Dysphonia and severe skin involvement (CDASI > 20) at the onset of dermatomyositis are significant predictors of a relapsing disease course.
  • Recording these features is essential for early identification of patients at high risk for dermatomyositis flares.
  • These findings can aid in proactive management and potentially prevent long-term complications associated with recurrent disease activity.